Clinical Trials, Phase II as Topic | Profiles RNSClinical Trials, Phase II as Topic | Profiles RNS

Clinical Trials, Phase II as Topic*Clinical Trials, Phase II as Topic ... "Clinical Trials, Phase II as Topic" by people in this website by year, and whether "Clinical Trials, Phase II as Topic" was a ... "Clinical Trials, Phase II as Topic" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ... Below are the most recent publications written about "Clinical Trials, Phase II as Topic" by people in Profiles. ...
more infohttp://profiles.ouhsc.edu/display/61092

John E. Baker, PhD | Professor | Medical College of WisconsinJohn E. Baker, PhD | Professor | Medical College of Wisconsin

Clinical Expertise *Clinical Trial. *Clinical Trials, Phase II as Topic. *Drugs, Investigational ... Clinical Trials Clinical trials are invaluable in testing new treatments, drugs and technologies. ... Were challenging existing models of care with new ideas across the spectrum of discovery-from basic science, to clinical ...
more infohttps://www.mcw.edu/academic-profiles/john-e-baker-phd

Comparative determinants of 5-year cardiovascular event rates in patients with unprotected left main coronary artery disease.Comparative determinants of 5-year cardiovascular event rates in patients with unprotected left main coronary artery disease.

Clinical Trials, Phase Iii As Topic. Comparative studies to verify the effectiveness of diagnostic, therapeutic, or ... Clinical Trials [8497 Associated Clinical Trials listed on BioPortfolio]. Predicting Physical Activity Change: an Epidemiologic ... Topics * All Topics Biotechnology Biotech Business Biotech Products Cancer Cardiovascular Dermatology Drug Discovery ... Topics. All Topics Biotechnology Biotech Business Biotech Products Cancer Cardiovascular Dermatology Drug Discovery ...
more infohttps://www.bioportfolio.com/resources/pmarticle/1781426/Comparative-determinants-of-5-year-cardiovascular-event-rates-in-patients-with-unprotected.html

Naptumomab estafenatox: a new immunoconjugate.Naptumomab estafenatox: a new immunoconjugate.

This review provides an overview of naptumomab, an immunotoxin, with encouraging clinical activity in Phase I trials. AREAS ... Clinical Trials, Phase I as Topic. Drug Design. Enterotoxins / adverse effects, chemistry, pharmacokinetics, pharmacology, ... This review provides an overview of naptumomab, an immunotoxin, with encouraging clinical activity in Phase I trials. AREAS ... 6854663 - Cerebral aneurysm: report of two cases and clinical update.. 3701343 - Clinical signs in the wernicke-korsakoff ...
more infohttp://www.biomedsearch.com/nih/Naptumomab-estafenatox-new-immunoconjugate/20053143.html

A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151...A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151...

Clinical Trials, Phase Iii As Topic. Comparative studies to verify the effectiveness of diagnostic, therapeutic, or ... Clinical Trial, Phase Iii. Work that is a report of a pre-planned, usually controlled, clinical study of the safety and ... Clinical Trials [16822 Associated Clinical Trials listed on BioPortfolio]. QUILT-2.023: A Study of ALT-803, a Fusion Protein ... Home » Topics » Melanoma » Research » A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With ...
more infohttps://www.bioportfolio.com/resources/pmarticle/2343903/A-Phase-Ib-Study-of-Pembrolizumab-as-Second-Line-Therapy-for-Chinese.html

Program Members | Yale Cancer CenterProgram Members | Yale Cancer Center

Clinical Trials as Topic; Graft vs Host Disease; Lymphoma; Bone Marrow Transplantation; Clinical Trials, Phase I as Topic; ... Clinical Trial, Phase I; Clinical Trial, Phase II; Clinical Trial, Phase III; Translational Medical Research ... Aging; Clinical Trials as Topic; Biostatistics; Patient Preference; Pragmatic Clinical Trials as Topic ... Lung Neoplasms; Medical Oncology; Thoracic Neoplasms; Clinical Trials, Phase I as Topic; Biomarkers, Pharmacological; Precision ...
more infohttps://www.yalecancercenter.org/research/programs/therapeutics/people/?page=8&tab=4

Robert Walter Makuch, PhD | Yale School of Public HealthRobert Walter Makuch, PhD | Yale School of Public Health

Infant, Premature; Public Health; Smoking Cessation; Clinical Trials, Phase IV as Topic; Biostatistics ... Selection of the treatment effect for sample size determination in a superiority clinical trial using a hybrid classical and ... Specialized Terms: Clinical studies; Methodology. Extensive Research Description. *Genetic and Brain Image Analysis of ... Clinical Studies of Methods to Stop/Prevent Smoking. *Biostatistical Design and Analysis Issues for Detection of Rare Adverse ...
more infohttps://medicine.yale.edu/ysph/people/robert_makuch-2.profile

FacultyFaculty

Infant, Premature; Public Health; Smoking Cessation; Clinical Trials, Phase IV as Topic; Biostatistics ... Clinical Professor of Epidemiology. Dr. Robert Hecht is the President of Pharos Global Health Advisors. He has more than 30 ... Grau is a clinical psychologist with training in health psychology and expertise in identifying the cognitive and emotional ... Assistant Clinical Professor of Public Health. Dr. Unni Karunakara was International President of Médecins Sans Frontières / ...
more infohttp://publichealth.yale.edu/global/people/list.aspx

Review of current thermal ablation treatm... & related info | MendeleyReview of current thermal ablation treatm... & related info | Mendeley

phase 1 clinical trial (topic). *phase 2 clinical trial (topic). *pleura effusion ... Thermal ablative therapies used in clinical practice to date include Radiofrequency Ablation (RFA), Microwave Ablation (MWA) ...
more infohttps://www.mendeley.com/research-papers/review-current-thermal-ablation-treatment-lung-cancer-potential-electrochemotherapy-means-treatment/

Comment je traite ... la leucemie myeloide chronique (LMC). - Hafraoui KaoutarComment je traite ... la leucemie myeloide chronique (LMC). - Hafraoui Kaoutar

Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Cytarabine/therapeutic use ; Enzyme Inhibitors/ ... The authors discuss the results of a phase I and three phase II trials reporting the efficacy of STI571 as treatment for CML ...
more infohttp://orbi.ulg.ac.be/handle/2268/9459

Time trends in the demographics of patients randomized  | Open-iTime trends in the demographics of patients randomized | Open-i

Time trends in the demographics of patients randomized in phase III trials.A good PS was defined as an Eastern Cooperative ... Clinical Trials, Phase III as Topic*. *Lung Neoplasms/drug therapy*/mortality*. *Small Cell Lung Carcinoma/drug therapy*/ ... pone-0042798-g002: Time trends in the demographics of patients randomized in phase III trials.A good PS was defined as an ... pone-0042798-g002: Time trends in the demographics of patients randomized in phase III trials.A good PS was defined as an ...
more infohttps://openi.nlm.nih.gov/detailedresult.php?img=PMC3412813_pone.0042798.g002&req=4

uterine corpus neoplasm drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engineuterine corpus neoplasm drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine

MeSH-minor] Clinical Trials, Phase I as Topic. Clinical Trials, Phase II as Topic. Drug Therapy, Combination. Female. Humans. ... Clinical Conference. Clinical Trial, Phase I. Clinical Trial, Phase II. Clinical Trial, Phase III. Clinical Trial, Phase IV. ... ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .. *[Source] The source of this record is MEDLINE®, a database of the ... Clinical Trials as Topic. Female. Humans. Multicenter Studies as Topic. Neoplasm Staging. Paclitaxel / administration & dosage ...
more infohttp://www.bmlsearch.com/?kwr=uterine+corpus+neoplasm+drug+therapy+2000:2010%5Bpubdate%5D&cxts=100&stmp=b1

recurrent kaposis sarcoma drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search enginerecurrent kaposi's sarcoma drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine

Clinical Trials, Phase I as Topic. Clinical Trials, Phase II as Topic. Clinical Trials, Phase III as Topic. Dogs. Drug Carriers ... Clinical Conference. Clinical Trial, Phase I. Clinical Trial, Phase II. Clinical Trial, Phase III. Clinical Trial, Phase IV. ... Clinical Trials as Topic / methods. Clinical Trials as Topic / statistics & numerical data. Female. Humans. Neoplasm Recurrence ... Publication-type] Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study ...
more infohttp://www.bmlsearch.com/?kwr=recurrent+kaposi

Synapse - Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image...Synapse - Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image...

... clinical trials, phase ii as topic; computer program; software; patient; phase 2 clinical trial (topic); medical informatics ... and patient-reported outcomes in a phase II clinical trial. Abstract:. In clinical trials, traditional monitoring methods, ... and patient-reported outcomes in a phase II clinical trial Journal Article ... Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response ...
more infohttps://synapse.mskcc.org/synapse/works/45480

ImmusanTs Celiac Vaccine Passed Phase I Clinical Trials - Celiac.com - Celiac Disease - Publications & Publicity - Celiac.com...ImmusanT's Celiac Vaccine Passed Phase I Clinical Trials - Celiac.com - Celiac Disease - Publications & Publicity - Celiac.com...

ImmusanTs Celiac Vaccine Passed Phase I Clinical TrialsCeliac.comHer son was diagnosed with celiac disease in 2006, at the age ... Topics. * Need Recovery Help Please. By ChargersFan, 46 minutes ago. in Celiac Disease - Post Diagnosis, Recovery/Treatment(s) ... ImmusanTs Celiac Vaccine Passed Phase I Clinical Trials - Celiac.com * Join our community!. Do you have questions about celiac ... ImmusanTs Celiac Vaccine Passed Phase I Clinical Trials. Celiac.com. Her son was diagnosed with celiac disease in 2006, at the ...
more infohttps://www.celiac.com/forums/topic/81369-immusants-celiac-vaccine-passed-phase-i-clinical-trials-celiaccom/

Andersson, Hanna, Dr. (0000-0003-3798-3322)Andersson, Hanna, Dr. (0000-0003-3798-3322)

... phase 2 clinical trial (topic), phase 3 clinical trial (topic), priority journal, protein interaction, renin angiotensin ...
more infohttp://uu.diva-portal.org/smash/person.jsf?pid=authority-person%3A15149

Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment...Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment...

Clinical Trials, Phase II as Topic. -. dc.subject.mesh. Drug Resistance. -. dc.subject.mesh. Enzyme Inhibitors. - ... A recent clinical trial has demonstrated a high response rate to stilboestrol given after a median of four previous oestrogen ... A recent clinical trial has demonstrated a high response rate to stilboestrol given after a median of four previous oestrogen ... Importantly, this trial is also comparing the sequence of tamoxifen followed by letrozole (or vice versa). A similar trial of ...
more infohttp://christie.openrepository.com/christie/handle/10541/84130

OPUS at UTS: The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to...OPUS at UTS: The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to...

Randomized Controlled Trials as Topic. en_US. dc.subject.mesh. Clinical Trials, Phase II as Topic. en_US. ... This paper describes the protocol for a phase II multi-site individually randomised controlled trial of the CRISP tool in ... This paper describes the protocol for a phase II multi-site individually randomised controlled trial of the CRISP tool in ... Study protocol for a randomised controlled trial. Walker, JG Macrae, F Winship, I Oberoi, J Saya, S Milton, S Bickerstaffe, A ...
more infohttps://opus.lib.uts.edu.au/handle/10453/126601

Bibliography | HTAi vortalBibliography | HTAi vortal

Clinical Trials, Phase II as Topic. Pietanza CM, Basch EM, Lash A, Schwartz LH, Ginsberg MS, Zhao B, et al. Harnessing ... and patient-reported outcomes in a phase II clinical trial. J Clin Oncol. 2013;31(16):2004-9. Abstract * RTF ... and patient-reported outcomes in a phase II clinical trial. J Clin Oncol. 2013;31(16):2004-9. Abstract * RTF ... and patient-reported outcomes in a phase II clinical trial. J Clin Oncol. 2013;31(16):2004-9. Abstract * RTF ...
more infohttp://vortal.htai.org/index.php?q=bibliography/author/947&sort=keyword&order=asc

DI-fusion Stemming resistance to HER-2 targeted therapy.DI-fusion Stemming resistance to HER-2 targeted therapy.

Clinical Trials, Phase III as Topic. Drug Resistance, Neoplasm. Humans. Neoplastic Stem Cells -- drug effects. ...
more infohttp://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/52340/Details

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab...Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab...

Clinical Trials, Phase II as Topic. Clinical Trials, Phase III as Topic ... Methods Data were pooled from phase II and III trials of patients who received nivolumab 1 mg/kg plus ipilimumab 3 mg/kg, every ... Purpose Approximately 40% of patients with advanced melanoma who received nivolumab combined with ipilimumab in clinical trials ... All of ICR repositoryICR Divisions & RM Clinical UnitsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitles ...
more infohttps://repository.icr.ac.uk/handle/internal/1565

Bibliography | HTAi vortalBibliography | HTAi vortal

Clinical Trials, Phase II as Topic. Pietanza CM, Basch EM, Lash A, Schwartz LH, Ginsberg MS, Zhao B, et al. Harnessing ... and patient-reported outcomes in a phase II clinical trial. J Clin Oncol. 2013;31(16):2004-9. Abstract * RTF ... and patient-reported outcomes in a phase II clinical trial. J Clin Oncol. 2013;31(16):2004-9. Abstract * RTF ... and patient-reported outcomes in a phase II clinical trial. J Clin Oncol. 2013;31(16):2004-9. Abstract * RTF ...
more infohttp://vortal.htai.org/index.php?q=bibliography/author/944&sort=keyword&order=desc

84 1.2 201084 1.2 2010

Clinical Trials, Phase III as Topic[MESH]*,Antibodies, Monoclonal/adverse effects/chemistry/immunology/*pharmacology[MESH]*, ... Phase 3 study lengths are typically two to four years, so results for some studies might be announced in 2010, but data from ... Phase 3 study lengths are typically two to four years, so results for some studies might be announced in 2010, but data from ... This overview of the 26 candidates provides a brief description of the background and the on-going Phase 3 studies of each mAb ...
more infohttp://www.kidney.de/mlpefetch.php?search=20065640

Search Articles | University of Toronto LibrariesSearch Articles | University of Toronto Libraries

Clinical Trials, Phase I as Topic , Precision Medicine ... clinical trials, phase i as topic (17) 17 Filter by. Remove ... Full Text Personalized medicine in a phase I clinical trials program: The MD Anderson Cancer Center Initiative ... We conducted a phase I... TRIAL , CTLA-4 BLOCKADE , LUNG-CANCER , MELANOMA , SOLID TUMORS , ONCOLOGY , IMMUNOTHERAPY , EARLY- ... PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials ...
more infohttps://query.library.utoronto.ca/index.php/search/q?kw=Author:Fu,%20Siqing